Replies to post #2360 on Enanta Pharmaceuticals Inc (ENTA)

[Jake2234]

Thanks for the reply. There is no phase 3 trial for EDP-235. It is in a standard risk phase 2. This won’t work (again, see real clinical results from the Paxlovid trial) and won’t get to phase 3.

Did I miss anything there?